207 related articles for article (PubMed ID: 28861795)
21. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
Sasaki K; Minaki H; Iwaki T
J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
[TBL] [Abstract][Full Text] [Related]
22. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
[TBL] [Abstract][Full Text] [Related]
23. Prions: proof of proteinaceous nature but problems with population polymorphisms.
Griffiths PD
Rev Med Virol; 2004; 14(6):341-3. PubMed ID: 15495195
[No Abstract] [Full Text] [Related]
24. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.
Collinge J; Sidle KC; Meads J; Ironside J; Hill AF
Nature; 1996 Oct; 383(6602):685-90. PubMed ID: 8878476
[TBL] [Abstract][Full Text] [Related]
25. Prion diseases: what is the neurotoxic molecule?
Chiesa R; Harris DA
Neurobiol Dis; 2001 Oct; 8(5):743-63. PubMed ID: 11592845
[TBL] [Abstract][Full Text] [Related]
26. Identification of a homology-independent linchpin domain controlling mouse and bank vole prion protein conversion.
Burke CM; Mark KMK; Walsh DJ; Noble GP; Steele AD; Diack AB; Manson JC; Watts JC; Supattapone S
PLoS Pathog; 2020 Sep; 16(9):e1008875. PubMed ID: 32898162
[TBL] [Abstract][Full Text] [Related]
27. Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.
Singh J; Udgaonkar JB
Biochemistry; 2015 Jul; 54(29):4431-42. PubMed ID: 26171558
[TBL] [Abstract][Full Text] [Related]
28. Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts.
Laffont-Proust I; Hässig R; Haïk S; Simon S; Grassi J; Fonta C; Faucheux BA; Moya KL
Biol Chem; 2006 Mar; 387(3):297-300. PubMed ID: 16542151
[TBL] [Abstract][Full Text] [Related]
29. [Mechanisms of neuroinvasion by prions: molecular principles and present state of research].
Brandner S; Klein MA; Aguzzi A
Schweiz Med Wochenschr; 2000 Mar; 130(12):435-42. PubMed ID: 10780058
[TBL] [Abstract][Full Text] [Related]
30. Cellular and sub-cellular pathology of animal prion diseases: relationship between morphological changes, accumulation of abnormal prion protein and clinical disease.
Jeffrey M; McGovern G; Sisó S; González L
Acta Neuropathol; 2011 Jan; 121(1):113-34. PubMed ID: 20532540
[TBL] [Abstract][Full Text] [Related]
31. RT-QuIC Assays for Prion Disease Detection and Diagnostics.
Orrù CD; Groveman BR; Hughson AG; Manca M; Raymond LD; Raymond GJ; Campbell KJ; Anson KJ; Kraus A; Caughey B
Methods Mol Biol; 2017; 1658():185-203. PubMed ID: 28861791
[TBL] [Abstract][Full Text] [Related]
32. Host Determinants of Prion Strain Diversity Independent of Prion Protein Genotype.
Crowell J; Hughson A; Caughey B; Bessen RA
J Virol; 2015 Oct; 89(20):10427-41. PubMed ID: 26246570
[TBL] [Abstract][Full Text] [Related]
33. Insights into prion strains and neurotoxicity.
Aguzzi A; Heikenwalder M; Polymenidou M
Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
[TBL] [Abstract][Full Text] [Related]
34. The prion's elusive reason for being.
Aguzzi A; Baumann F; Bremer J
Annu Rev Neurosci; 2008; 31():439-77. PubMed ID: 18558863
[TBL] [Abstract][Full Text] [Related]
35. The interpretation of disease phenotypes to identify TSE strains in mice: characterisation of BSE using PrPSc distribution patterns in the brain.
Corda E; Beck KE; Sallis RE; Vickery CM; Denyer M; Webb PR; Bellworthy SJ; Spencer YI; Simmons MM; Spiropoulos J
Vet Res; 2012 Dec; 43(1):86. PubMed ID: 23245876
[TBL] [Abstract][Full Text] [Related]
36. Differential solubility of prions is associated in manifold phenotypes.
Kuczius T; Karch H; Groschup MH
Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
[TBL] [Abstract][Full Text] [Related]
37. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
38. The state of the prion.
Weissmann C
Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
[TBL] [Abstract][Full Text] [Related]
39. Expression of doppel in the CNS of mice does not modulate transmissible spongiform encephalopathy disease.
Tuzi NL; Gall E; Melton D; Manson JC
J Gen Virol; 2002 Mar; 83(Pt 3):705-711. PubMed ID: 11842265
[TBL] [Abstract][Full Text] [Related]
40. Oxidative and Inflammatory Events in Prion Diseases: Can They Be Therapeutic Targets?
Prasad KN; Bondy SC
Curr Aging Sci; 2019; 11(4):216-225. PubMed ID: 30636622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
